Breakthrough T1D – Advancing Technologies to Enhance Engraftment in Cell Therapy for T1D
Event details
| Date | 10.01.2025 |
| Category | Call for proposal |
Aim: The goal of this funding opportunity is to advance technologies that support the engraftment of insulin-producing cells following transplantation at extrahepatic sites for T1D cell therapy.
Proposals eligible for consideration will focus on strategies addressing the various challenges encountered at alternative transplantation sites during the peri-transplant period due to inflammation, hypoxia, and poor vascularization to enhance survival, engraftment, and function of transplanted cells.
Funding: $600,000
Duration: 2 years
Eligibility: Applications may be submitted by domestic (US) and foreign non-profit organizations and public and private entities, such as universities, colleges, hospitals, laboratories, units of state and local governments and, where relevant, eligible agencies of the federal government.
Applicants must hold an MD, DMD, DVM, PhD, or equivalent degree, and hold a faculty position or equivalent at a college, university, medical school or other research facility. There are no citizenship requirements
How to Apply: Applicants should submit an LOI, [2 pages maximum] online via RMS360 to be considered for a full proposal request. The LOI template provided on the RMS360 website must be used to complete the application to be considered for a full proposal request.
Deadline:
Proposals eligible for consideration will focus on strategies addressing the various challenges encountered at alternative transplantation sites during the peri-transplant period due to inflammation, hypoxia, and poor vascularization to enhance survival, engraftment, and function of transplanted cells.
Funding: $600,000
Duration: 2 years
Eligibility: Applications may be submitted by domestic (US) and foreign non-profit organizations and public and private entities, such as universities, colleges, hospitals, laboratories, units of state and local governments and, where relevant, eligible agencies of the federal government.
Applicants must hold an MD, DMD, DVM, PhD, or equivalent degree, and hold a faculty position or equivalent at a college, university, medical school or other research facility. There are no citizenship requirements
How to Apply: Applicants should submit an LOI, [2 pages maximum] online via RMS360 to be considered for a full proposal request. The LOI template provided on the RMS360 website must be used to complete the application to be considered for a full proposal request.
Deadline:
- Letter of Intent: 10 January 2025 (outcome notification: 21 Jan)
- Full proposal: 21 February 2025
- More information about the call is available here.
- The proposal should be submitted on the online portal RMS360.
- For any other questions, please contact the Research Office.
Practical information
- General public
- Free